Search - tctmd.com

Displaying 1 - 8 of 8

Sort: Relevancy | Date

Presentation Scripps 2016

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

Presenter: Brian Whisenant

February 04, 2016

Presentation

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

Presenter: Vivek Y. Reddy

November 19, 2014

Presentation LAA 2014

LARIAT: Clinical Trial Results & Future Trials

Presenter: Steven J. Yakubov

July 19, 2014

Presentation TCT 2013

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Presenter: Ted Feldman

October 30, 2013

Presentation TCT 2013

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

Presenter: Paul Grayburn

October 30, 2013

Presentation TCT 2013

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Presenter: Brian Whisenant

October 30, 2013

Presentation TCT 2012

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

Presenter: Saibal Kar

October 23, 2012

Presentation ISET 2012

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Presenter: Ramon Quesada

January 16, 2012

Advertisement

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

Percutaneous LAA Closure vs Warfarin for A-fib:A Randomized Clinical Trial

LARIAT: Clinical Trial Results & Future Trials

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

WaveCrest (Coherex Medical): Device Iteration, Human Outcomes, and Clinical Trial Directions

LAA Closure: The Watchman Devices, Lessons Learned from the Clinical Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content